Chemplast Sanmar Limited

NSE:CHEMPLASTS.NS

517.75 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12011 Q4
Revenue 11,448.911,468.38,8819,877.59,964.111,468.311,885.811,943.714,11318,044.9814,497.816,729.99,603.713,402.0710,862.39,263.36,8425,209.919
Cost of Revenue 7,876.17,474.96,032.86,562.67,249.77,474.97,770.97,820.19,040.812,897.728,327.110,765.55,988.88,602.456,207.85,0133,524.41,203.119
Gross Profit 3,572.83,993.42,848.23,314.92,714.43,993.44,114.94,123.65,072.25,147.266,170.75,964.43,614.94,799.624,654.54,250.33,317.64,006.8
Gross Profit Ratio 0.3120.3480.3210.3360.2720.3480.3460.3450.3590.2850.4260.3570.3760.3580.4290.4590.4850.769
Reseach & Development Expenses 03,951.90001,897.8000000000000
General & Administrative Expenses 000000000000000000
Selling & Marketing Expenses 000000000000000000
SG&A 2,779390.82,494.12,465381.52,628.42,996.62,757.82,767.82,2582,329.42,202.31,825.7524.39292.6313.5297.74,160.423
Other Expenses 115126.2126.5372.3179.7309.3165.2166.9157.5-470.01130.5218.1138.7-66.2830.325.20107.209
Operating Expenses 2,7793,353.83,2903,208.73,384.13,353.83,679.83,472.83,536.31,427.52,973.42,831.22,411.11,138.252,155.82,235.13,030.44,053.214
Operating Income 793.8639.6-315.3478.5-669.7948.9600.3817.71,693.42,327.643,327.83,351.31,342.52,167.451,833.61,029.31,360.6-46.414
Operating Income Ratio 0.0690.056-0.0360.048-0.0670.0830.0510.0680.120.1290.230.20.140.1620.1690.1110.199-0.009
Total Other Income Expenses Net -471.5-74.7-468.1-386-261.9-384-394.6-399.7-1,166.9473.32-373.7-1,489.2-1,004.22,640.76539-1,212.8-2,215.05-266.359
Income Before Tax 322.3564.9-783.492.5-931.6564.9205.7418526.52,800.962,954.11,862.1338.34,808.212,372.6-183.5-854.45-312.773
Income Before Tax Ratio 0.0280.049-0.0880.009-0.0930.0490.0170.0350.0370.1550.2040.1110.0350.3590.218-0.02-0.125-0.06
Income Tax Expense 83.4104.1110.4-168-291.9104.1-65.732.6120.6484.68585.5348.750.11,165.47773.6-63.7284.8-55.948
Net Income 238.9460.8-893.8260.5-639.7460.8271.4385.4405.92,316.282,368.61,513.4288.23,642.741,599-119.8-569.65-256.825
Net Income Ratio 0.0210.04-0.1010.026-0.0640.040.0230.0320.0290.1280.1630.090.030.2720.147-0.013-0.083-0.049
EPS 1.512.92-5.651.65-4.052.911.722.442.5714.6714.9810.511.8223.0310.11-0.89-4.25-0.32
EPS Diluted 1.512.92-5.651.65-4.052.911.722.442.5714.6714.9810.511.8223.0310.11-0.76-4.25-0.32
EBITDA 1,240.9209.860.8831.8-165.51,283.5946.71,151.22,098.92,729.743,658.13,682.11,650.62,521.482,163.71,346.11,673.45194.389
EBITDA Ratio 0.1080.0180.0070.084-0.0170.1120.080.0960.1490.1510.2520.220.1720.1880.1990.1450.2450.037